China Vaccine Maker Inks Canada Deal to Develop Second Shot
- CanSino will test Precision Nanosystems’ mRNA vaccine
- Co. among leading developers with military-backed candidate
This article is for subscribers only.
Leading Chinese vaccine developer CanSino Biologics Inc. has inked a deal to test and sell a separate Canadian vaccine candidate as the race for immunization intensifies globally.
In addition to developing its own vaccine together with the Chinese military, CanSino will partner with Vancouver-based Precision NanoSystems Inc. to co-develop another potential vaccine, according to a joint press release Wednesday.